These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35623325)

  • 1. Viruses to the rescue-Use of bacteriophage to treat resistant pulmonary infections.
    Toporek A; Lechtzin N
    Cell; 2022 May; 185(11):1807-1808. PubMed ID: 35623325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
    Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785625
    [No Abstract]   [Full Text] [Related]  

  • 3. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.
    Dedrick RM; Guerrero-Bustamante CA; Garlena RA; Russell DA; Ford K; Harris K; Gilmour KC; Soothill J; Jacobs-Sera D; Schooley RT; Hatfull GF; Spencer H
    Nat Med; 2019 May; 25(5):730-733. PubMed ID: 31068712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection.
    Nick JA; Dedrick RM; Gray AL; Vladar EK; Smith BE; Freeman KG; Malcolm KC; Epperson LE; Hasan NA; Hendrix J; Callahan K; Walton K; Vestal B; Wheeler E; Rysavy NM; Poch K; Caceres S; Lovell VK; Hisert KB; de Moura VC; Chatterjee D; De P; Weakly N; Martiniano SL; Lynch DA; Daley CL; Strong M; Jia F; Hatfull GF; Davidson RM
    Cell; 2022 May; 185(11):1860-1874.e12. PubMed ID: 35568033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Receives First Genetically Engineered Phage Treatment.
    Abbasi J
    JAMA; 2019 Jul; 322(2):107. PubMed ID: 31287505
    [No Abstract]   [Full Text] [Related]  

  • 6. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Dedrick RM; Smith BE; Cristinziano M; Freeman KG; Jacobs-Sera D; Belessis Y; Whitney Brown A; Cohen KA; Davidson RM; van Duin D; Gainey A; Garcia CB; Robert George CR; Haidar G; Ip W; Iredell J; Khatami A; Little JS; Malmivaara K; McMullan BJ; Michalik DE; Moscatelli A; Nick JA; Tupayachi Ortiz MG; Polenakovik HM; Robinson PD; Skurnik M; Solomon DA; Soothill J; Spencer H; Wark P; Worth A; Schooley RT; Benson CA; Hatfull GF
    Clin Infect Dis; 2023 Jan; 76(1):103-112. PubMed ID: 35676823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled Bacteriophage Therapy for Multi-Drug Resistant
    Winzig F; Gandhi S; Lee A; Würstle S; Stanley GL; Capuano I; Neuringer I; Koff JL; Turner PE; Chan BK
    Yale J Biol Med; 2022 Dec; 95(4):413-427. PubMed ID: 36568830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease caused by non-tuberculous mycobacteria in children with cystic fibrosis.
    Lu M; Saddi V; Britton PN; Selvadurai H; Robinson PD; Pandit C; Marais BJ; Fitzgerald DA
    Paediatr Respir Rev; 2019 Feb; 29():42-52. PubMed ID: 30473423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis.
    Laudone TW; Garner L; Kam CW; Esther CR; McKinzie CJ
    Pediatr Pulmonol; 2021 Feb; 56 Suppl 1():S55-S68. PubMed ID: 32609433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for Phage Therapy Against
    Senhaji-Kacha A; Esteban J; Garcia-Quintanilla M
    Front Microbiol; 2020; 11():609017. PubMed ID: 33537013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia.
    Dan JM; Lehman SM; Al-Kolla R; Penziner S; Afshar K; Yung G; Golts E; Law N; Logan C; Kovach Z; Mearns G; Schooley RT; Aslam S; Crotty S
    J Infect Dis; 2023 Feb; 227(3):311-316. PubMed ID: 36082999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered phages stymie drug-resistant infection.
    Fox A
    Science; 2019 May; 364(6440):518-519. PubMed ID: 31073047
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium bolletii Lung Disease in Cystic Fibrosis.
    Rollet-Cohen V; Roux AL; Le Bourgeois M; Sapriel G; El Bahri M; Jais JP; Heym B; Mougari F; Raskine L; Véziris N; Gaillard JL; Sermet-Gaudelus I
    Chest; 2019 Aug; 156(2):247-254. PubMed ID: 30935892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice.
    Tissot A; Thomas MF; Corris PA; Brodlie M
    BMC Pulm Med; 2018 May; 18(1):86. PubMed ID: 29788939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
    Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
    Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.